Iron infusion for anemia in ovarian cancer
Part of Blood & lymphatic, Cancer clinical trials.
This trial tests whether giving iron through an IV can help prevent or treat low red blood cell counts (anemia) in people with ovarian cancer. The goal is to reduce the need for blood transfusions and improve quality of life during treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a woman aged 18 or older.
- You must have a confirmed diagnosis of ovarian cancer that has spread beyond the ovary (stage IC or higher).
- You should have had no more than two prior chemotherapy treatments.
- You must be able to have an intravenous (IV) iron infusion and possibly a blood transfusion.
- You must not be allergic to IV iron or have conditions like iron overload or active hepatitis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 study tests whether giving a specific iron medicine before major gynecologic cancer surgery can improve recovery. It’s mainly for people with low blood counts from low iron stores before surgery.
This trial tests whether giving iron (iron sucrose) can reduce anemia during chemotherapy before curative surgery. It may help you feel better and have smoother treatment by improving low blood counts caused by iron deficiency.
This Phase 3 study tests whether giving ferric carboxymaltose (an IV iron treatment) helps people with advanced stomach or stomach–esophagus cancer and iron-deficiency anemia. The goal is to improve safety and how well the standard first-line cancer treatment works.
This trial compares two types of IV iron treatments to see which one works better for people who have anemia after gastric cancer surgery. If you're eligible, you could get either ferric carboxymaltose or iron sucrose to help boost your iron levels and improve your anemia.
This trial tests whether giving iron directly into the bloodstream before surgery improves recovery for people with colorectal cancer who have low iron but are not anemic. It may help reduce fatigue and the need for blood transfusions after surgery.
This trial studies whether giving iron through a vein (IV) helps improve anemia caused by heavy uterine bleeding. You may join if you were treated in the emergency department, can go home, and can return for follow-up checks in the next several weeks.
Hear when a new Anaemia in Ovarian Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.